Journal
CLINICAL NUCLEAR MEDICINE
Volume 39, Issue 8, Pages 742-743Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/RLU.0000000000000495
Keywords
C-11-choline PET/CT; prostate cancer; biochemical recurrence; diffuse large-B-cell lymphoma
Ask authors/readers for more resources
The main indication for C-11-choline PET/CT in prostate cancer patients is the early localization of biochemical recurrence after radical treatment. However, any C-11-choline uptake should be assessed in terms of physiological distribution and patterns of tumor spread. Therefore, tracer-avid lesions in unexpected sites should be carefully addressed because the diagnosis of other malignancies has important therapeutic implications. We present a patient with biochemical recurrence of prostate cancer treated with radiotherapy. C-11-choline PET/CT showed local recurrence and inguinal lymph node uptake. Because of its location beyond typically prostatic lymphatic spread, resection was performed. Histology confirmed a diffuse large B-cell lymphoma.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available